INTRODUCTION
Both traditional and new infectious diseases in recent years have challenged global health. Conventional contagious diseases have not been eliminated but instead have intensified. To monitor and analyze infectious disease cases worldwide, tracking and prediction of the development of infectious diseases are required. From 2023, the number of COVID-19 cases has significantly decreased. The subsequent spread of COVID-19 may fluctuate. The emergence of new strains, climate change, and large-scale population flow will affect the record period and virus transmission. Currently, COVID-19 persists, and the current epidemic infection status cannot be considered to indicate the eradication of the disease. Recently, the rate of positive influenza virus tests has continued to rise in many countries, thus indicating that the epidemic form of influenza virus is increasing, and active prevention and control measures are required. Global health continues to be affected by infectious diseases such as Mpox, dengue, and chikungunya.
By using Shusi Tech’s Global Epidemic Information Monitoring System, we analyzed the prevalence of infectious diseases worldwide and have described other types of infectious diseases with relatively low incidence from January 24, 2023 to February 24, 2023, in the greatest detail possible (Fig 1).
COVID-19
As a result of the Chinese government’s changes in prevention and control policies for COVID-19, the international community has officially entered the post-pandemic era. After an exponential rise in SARS-CoV-2 infections in China, the number of cases has fallen rapidly. However, the international community continues to see a surge in new infectious cases (Fig 2). After the pandemic, international cooperation will play a major role in public health. The Omicron variant of SARS-CoV-2, despite carrying many mutations, is currently the most prevalent virus variant spreading.
MPOX
Because the Mpox virus is transmitted primarily from animals to humans, and chains of human-to-human transmission are limited, cases of MPOX infections have frequently been detected near tropical rainforests, which are home a variety of animals capable of carrying the virus [1]. Global attention has been paid to MPOX since the WHO declared the outbreak a public health emergency of international concern (PHEIC). Nevertheless, monkeypox viral infections have decreased in recent years. In many countries, monkeypox outbreaks have subsided (Table 1). Some West African and Central African countries continue to report cases. As reported by Nature, the WHO’s director-general has stated that MPOX remains a public-health emergency [2].
Record period | Location | Cumulative cases (deaths) reported during record period | Cumulative cases (deaths) reported since 1/1/2023 | Data source |
---|---|---|---|---|
04/02/2023–04/02/2023 | Hong Kong | 1 | HK Government News | |
13/06/2022–31/01/2023 | Chile | 1411 (2) | WHO | |
19/05/2022–25/01/2023 | Spain | 7518 (3) | WHO | |
23/01/2023–29/01/2023 | Japan | 6 | 7 | Japan National Institute of Infectious Diseases |
30/01/2023–05/02/2023 | 2 | 10 | ||
06/02/2023–12/02/2023 | 1 | 11 | ||
01/01/2023–25/01/2023 | Nigeria | 775 (7) | WHO | |
28/05/2022–31/01/2023 | Mexico | 3768 (4) | WHO | |
26/06/2022–25/01/2023 | Peru | 3723 (15) | WHO | |
18/05/2022–01/02/2023 | USA | 30123 (28) | U.S. CDC | |
23/06/2022–25/01/2023 | Columbia | 4066 | WHO | |
01/01/2022–25/01/2023 | Congo | 348 | WHO | |
20/05/2022–25/01/2023 | France | 4128 | WHO | |
08/06/2022–30/01/2023 | Brazil | 10745 (15) | Brazil Ministry of Health | |
21/02/2023–21/02/2023 | Paraguay | 1 | Outbreak News Today |
CHOLERA
Globally, cholera continues to be a major cause of outbreaks, particularly in areas with inadequate water, sanitation, and hygiene services. Earlier this year, the Euphrates River in Syria was contaminated, thus causing an outbreak in Africa. Pollution is partly due to damage to water treatment systems caused by war and earthquakes. In addition, as shown in Table 2, Haiti continues to experience cholera outbreaks.
Record period | Location | Cumulative cases (deaths) reported during record period | Cumulative cases (deaths) reported since 1/1/2023 | Data source |
---|---|---|---|---|
11/04/2022–05/02/2023 | Zambia | 1934 (18) | Outbreak News Today | |
01/01/2023–29/01/2023 | Somalia | 916 (1) | 916 | WHO Regional Office for the Eastern Mediterranean |
03/03/2022–03/02/2023 | Malawi | 36943 (1210) | Outbreak News Today | |
30/09/2022–24/01/2023 | Haiti | 26435 (511) | WHO Regional Office for the Americas | |
30/09/2022–12/02/2023 | 31032 (594) | |||
25/01/2023–31/01/2023 | 1311 (49) | |||
07/02/2023–12/02/2023 | 1383 (34) | |||
01/01/2023–04/02/2023 | Democratic Republic of the Congo | 4386 (16) | 4386 | WHO Regional Office for the Americas |
27/08/2022–26/01/2023 | Ethiopia | 1027 (28) | WHO Regional Office for Africa | |
29/01/2023–04/02/2023 | 9 | 1083 (28) |
DENGUE
Known as a mosquito-borne disease, dengue virus is one of four types of positive-sense single-stranded RNA viruses (DENV-1 to DENV-4) [3]. As shown in Table 3, the greatest burden of the disease was reported in tropical and subtropical regions, such as Singapore and Malaysia. Singapore has experienced dengue epidemics in multi-annual cycles since dengue outbreaks were first documented in 1901, owing to changes in the predominant serotype [4].
Record period | Location | Cumulative cases (deaths) reported during record period | Cumulative cases (deaths) reported since 1/1/2023 | Data source |
---|---|---|---|---|
29/01/2023–04/02/2023 | Taiwan, China | 1 | 8 | China Taiwan Disease Control Agency |
05/02/2023–11/02/2023 | 3 | 11 | ||
22/01/2023–28/01/2023 | Singapore | 186 | 1019 | Health Ministry of Singapore |
29/01/2023–04/02/2023 | 224 | 1242 | ||
01/01/2023–12/02/2023 | 1469 | |||
05/02/2023–11/02/2023 | 219 | |||
12/02/2023–18/02/2023 | 149 | 1609 | ||
01/01/2022–31/01/2023 | Thailand | 2683 | 2683 | Thailand Ministry of Health |
28/01/2023–03/02/2023 | Sri Lanka | 1150 | Sri Lanka Ministry of Health | |
01/01/2023–17/02/2023 | Peru | 11585 (16) | Outbreak News Today | |
01/01/2023–31/01/2023 | Bangladesh | 566 (6) | Bangladesh Ministry of Health and Family Welfare | |
01/01/2023–22/02/2023 | Malaysia | 16427 (9) | Outbreak News Today | |
22/01/2023–28/01/2023 | Korea | 1 | 5 | Korea CDC |
29/01/2023–04/02/2023 | 1 | 9 | ||
05/02/2023–11/02/2023 | 1 | 12 | ||
01/01/2023–28/01/2023 | Haiti | 27099 (560) | WHO Regional Office for the Americas | |
01/01/2023–28/01/2023 | Philippines | 7804 (22) | Philippine Ministry of Health | |
01/02/2023–19/02/2023 | France | 13 | Outbreak News Today | |
01/01/2023–04/02/2023 | Bolivia | 3437 (13) | Outbreak News Today | |
01/01/2023–08/02/2023 | 4230 (17) | 4230 (17) | ||
01/01/2023–14/02/2023 | 6453 (26) | 6453 (26) | ||
01/01/2023–22/02/2023 | 8909 (29) | 8909 (29) | ||
22/01/2023–28/01/2023 | Paraguay | 29 | 95 | Paraguay Health Ministry |
29/01/2023–04/02/2023 | 25 | 169 | ||
01/02/2023–21/02/2023 | 203 | |||
29/01/2023–04/02/2023 | Afghanistan | 6 | 1304 (2) | WHO Regional Office for the Eastern Mediterranean |
05/02/2023–11/02/2023 | 7 | 1311 (2) |
MEASLES
Measles is a highly contagious viral disease caused by the measles virus, which is transmitted primarily via respiratory droplets and aerosols [5]. As shown in Table 4, most new cases were reported in South Sudan, where immunization campaigns are limited. In Paraguay, the first case of measles since 1998 was reported on January 23, 2023.
Record period | Location | Cumulative cases (deaths) reported during record period | Cumulative cases (deaths) reported since 1/1/2023 | Data source |
---|---|---|---|---|
01/01/2023–23/01/2023 | Paraguay | 1 | 1 | WHO |
01/01/2023–01/02/2023 | South Sudan | 4339 (46) | WHO | |
01/01/2023–13/01/2023 | New Zealand | 1 | Outbreak News Today | |
01/01/2023–18/02/2023 | Australia | 8 | Outbreak News Today | |
20/02/2023–20/02/2023 | Canada | 1 | Outbreak News Today | |
24/01/2023–17/02/2023 | South Africa | 4 | Outbreak News Today |
INFLUENZA
Influenza viruses can be transmitted through the respiratory tract or through direct contact. According to World Health Organization statistics, 1 billion people have been estimated to contract seasonal influenza each year, of whom 650,000 die (nearly one death due to influenza every 49 seconds). As shown in Table 5, influenza is prevalent primarily in European and American countries, such as the United States and France. Data indicate that influenza poses a deadly threat. Many parts of the world, particularly Southeast Asia, are experiencing a co-epidemic of influenza with COVID-19. Children have a significantly higher proportion of co-infection and more severe outcomes of co-infection than adults. Consequently, COVID-19 and influenza continue to pose a risk of co-infection this season. The transmission of influenza virus has been decreased by non-pharmacological interventions, such as long-term mask wearing and social distancing. Non-drug interventions may lead to a decrease in human immunity to influenza viruses, thereby increasing the susceptibility of influenza viruses.
Record period | Location | Cumulative cases (deaths) reported during record period | Data source |
---|---|---|---|
22/01/2023–04/02/2023 | Canada | 575 | Public Health Agency of Canada |
29/01/2023–11/02/2023 | U.S.A. | 2262 | U.S. CDC |
02/01/2023–12/02/2023 | France | 8993 | World Health Organization |
02/01/2023–12/02/2023 | Denmark | 7756 | World Health Organization |
CHIKUNGUNYA VIRUS
Chikungunya virus (CHIKV) has been identified in more than 110 countries in Asia, Africa, Europe, and the Americas. Among these regions, Asia and America are most affected by chikungunya fever. The similar symptoms of chikungunya and dengue or Zika infections may result in misdiagnosis. Currently, no specific antiviral drug treatment or commercial vaccine is available to protect against CHIKV viral infection. In some countries, polio has been reported to have spread over the past month. It is worth noting that the number of polio cases is steadily increasing in Paraguay (Table 6).
Record period | Location | Cumulative cases (deaths) reported during record period | Cumulative cases (deaths) reported since 1/1/2023 | Data source |
---|---|---|---|---|
01/01/2023–11/02/2023 | Brazil | 5138 | WHO Regional Office for the Americas | |
01/01/2023–08/02/2023 | Malaysia | 72 | Outbreak News Today | |
18/02/2023–18/02/2023 | Argentina | 3 | Outbreak News Today | |
29/01/2023–21/02/2023 | Paraguay | 11864 | Outbreak News Today | |
29/01/2023–04/02/2023 | Peru | 53 | 143 | WHO Regional Office for the Americas |
POLIO
As shown in Table 7, countries such as the Democratic Republic of the Congo, Chad, the Central African Republic, and Indonesia have reported polio cases. Polo transmission is increasing in the Democratic Republic of the Congo and may be a matter of concern. The WHO has estimated that one of every 200 infections may result in irreversible paralysis. Five to ten percent of people who are paralyzed die when their breathing muscles become immobile. Under-immunized areas can experience polio outbreaks, and polio continues to spread in parts of Africa, Asia, and Europe. The disease might potentially return if the goal of eliminating polio is not achieved.
Record period | Location | Cumulative cases | Data source |
---|---|---|---|
Reported during record period | |||
25/01/2023–31/01/2023 | Central African Republic | 1 | Global Polio Website |
25/01/2023–31/01/2023 | Yemen | 1 | |
25/01/2023–31/01/2023 | Indonesia | 1 | |
25/01/2023–31/01/2023 | Nigeria | 1 | |
25/01/2023–14/02/2023 | Chad | 16 | |
01/02/2023–07/02/2023 | Algeria | 1 | |
01/02/2023–07/02/2023 | Mali | 1 | |
01/02/2023–14/02/2023 | Democratic Republic of the Congo | 28 | |
08/02/2023–14/02/2023 | Nigeria | 1 | |
08/02/2023–14/02/2023 | Indonesia | 1 |
HEPATITIS C
Hepatitis C is an infectious disease caused by the hepatitis C virus. This liver disease is characterized by inflammation and necrosis which caused by infectious factors. Hepatitis C virus is an RNA virus present in the liver cells and blood of infected people. The hepatitis C virus causes the body to mount an immune response, thereby causing damage to liver cells and inflammation of the liver. Hepatitis C infection can cause chronic liver inflammation, necrosis, and fibrosis. Approximately 15% of people with chronic hepatitis C develop liver cancer, which is life-threatening. Because HCV symptoms and signs are unclear in patients, early detection is the only way to diagnose HCV infection. In some Asian countries, hepatitis C cases have been reported over the past month (Table 8).
OTHER INFECTIOUS DISEASES
In the past month, some infectious diseases have shown regional epidemiological trends. Several epidemic diseases are listed in Table 9, including Nipah virus disease, Japanese encephalitis, leishmaniasis, anthrax, amoebic dysentery, malaria, scarlet fever, hand-foot-mouth disease, Salmonella, hantavirus, pneumococcal, mumps, Zika virus, Leptospira, tuberculosis, Nipah virus, diphtheria, and legionella.
Record period | Location | Cumulative cases (deaths) reported during record period | Cumulative cases | Data source |
---|---|---|---|---|
Reported since 1/1/2022 | ||||
Epidemic encephalitis B | ||||
18/02/2023–18/02/2023 | India | 5 | ProMED-mail | |
Leishmaniasis | ||||
01/01/2023–04/02/2023 | Paraguay | 13 | Outbreak News Today | |
Anthracnose | Bulgaria | 1 | ProMED-mail | |
06/02/2023–06/02/2023 | ||||
Amoebic dysentery | Bulgaria | 1 | ProMED-mail | |
05/02/2023–11/02/2023 | Taiwan, China | 7 | 33 | Taiwan Disease Control Agency of China |
Malaria | ||||
01/01/2023–12/02/2023 | Japan | 3 | ||
29/01/2023–04/02/2023 | Korea | 1 | 5 | Korea CDC |
Scarlet fever | ||||
01/01/2023–31/01/2023 | Thailand | 48 | ProMED-mail | |
16/01/2023–12/02/2023 | U.K. | 6049 | U.K. Health and Safety Executive | |
Meningitis | ||||
01/10/2022–04/02/2023 | Nigeria | 398 (38) | WHO Regional Office for Africa | |
Hand foot and mouth disease | ||||
01/01/2023–02/04/2023 | Philippines | 3250 | Outbreak News Today | |
01/01/2023–31/01/2023 | Thailand | 2821 | ||
01/01/2023–01/02/2023 | U.S.A. | 42 | Outbreak News Today | |
Salmonella | ||||
29/01/2023–04/02/2023 | U.S.A. | 219 | 1961 | U.S. CDC |
Hantavirus | ||||
01/01/2023–15/02/2023 | Panama | 4 (1) | ProMED-mail | |
01/12/2022–15/02/2023 | Chile | 2 | ProMED-mail | |
05/02/2023–11/02/2023 | Taiwan, China | 1 | ProMED-mail | |
Pneumococcus | ||||
29/01/2023–11/02/2023 | Taiwan, China | 18 | 68 | Taiwan Disease Control Agency of China |
29/01/2023–04/02/2023 | U.S.A. | 201 | 1807 | U.S. CDC |
30/01/2023–05/02/2023 | Japan | 19 | 166 | Japan National Institute of Infectious Diseases |
Mumps | ||||
29/01/2023–11/02/2023 | Korea | 220 | 673 | Korea CDC |
Zika virus | ||||
01/01/2023–04/02/2023 | Peru | 74 | ProMED-mail | |
01/01/2023–04/02/2023 | Colombia | 46 | WHO Regional Office for the Americas | |
Leptospira | ||||
28/01/2023–10/02/2023 | Sri Lanka | 95 | 726 | Ministry of Health, Sri Lanka |
Tuberculosis | ||||
01/01/2023–31/01/2023 | Thailand | 888 (1) | ProMED-mail | |
23/01/2023–05/02/2023 | Japan | 373 | 1936 | Japan National Institute of Infectious Diseases |
23/01/2023–05/02/2023 | Korea | 738 | 2270 | Korea CDC |
Nipah virus | ||||
01/01/2023–20/02/2023 | Bangladesh | 11 (8) | World Health Organization | |
Invasive group A streptococcus | ||||
01/01/2023–31/01/2023 | Denmark | 99 | EU CDC | |
01/09/2022–01/02/2023 | Croatia | 15 (4) | EU CDC | |
Diphtheria | ||||
01/01/2023–29/01/2023 | France | 127 (17) | EU CDC | |
01/01/2023–08/02/2023 | Dominican Republic | 4 (1) | ProMED-mail | |
23/01/2023–05/02/2023 | Nigeria | 56 (4) | Nigeria CDC | |
25/01/2023–02/02/2023 | Germany | 31 | 147 | |
29/01/2023–05/02/2023 | Afghanistan | 13 | 1082 | |
Legionella | ||||
05/02/2023–11/02/2023 | Hong Kong, China | 2 | 7 | Center for Health Protection, Hong Kong, China |
29/01/2023–04/02/2023 | U.S.A. | 16 | 236 | U.S. CDC |
29/01/2023–04/02/2023 | Korea | 7 | 38 | Korea CDC |
29/01/2023–11/02/2023 | Taiwan, China | 12 | 67 | Taiwan Disease Control Agency of China |
30/01/2023–05/02/2023 | Japan | 13 | 126 | Japan National Institute of Infectious Diseases |
CONCLUSION
China has entered the post-epidemic era by adjusting its COVID-19 prevention and control policies. New cases of SARS-CoV-2 infection were found primarily in the Western Pacific, Europe, and the Americas. The Omicron variant of SARS-CoV-2 has been reported to be the predominant variant spreading. To prevent SARS-CoV-2 from mutating, more effective strategies should be implemented. According to a Nature article, Mpox was predicted to be removed from the list of PHEIC, owing to a decreasing number of new cases reported. However, no vaccine is available to prevent monkeypox viral infection. Therefore, monkeypox virus surveillance should not be relaxed. Several countries and areas lack water, sanitation, and hygiene services because of wars and natural disasters. Consequently, combatting infectious diseases in this environment is difficult. To curb the international epidemic in advance, the international community should provide support to these countries. Given the current prevalence of infectious diseases in many countries, monitoring and collecting data on global outbreaks will alert the international community to ongoing outbreaks.